Micra™ AV and Micra™ VR leadless pacemakers
The Micra™ AV and Micra™ VR leadless pacemakers are implantable, programmable cardiac devices used to monitor and regulate a patient’s heart rate.
Download Brochure
Overview
Model specifications
| Parameter |
Micra AV2 |
Micra VR3 |
|---|---|---|
| Pacing mode |
VVI, VVIR, VOO, OVO, VDD, VDI, ODO, OFF |
VVI, VVIR, VOO, OVO, OFF |
| Mass |
1.75 g |
1.75 g |
| Volume |
0.8 cc |
0.8 cc |
| Electrode spacing |
18 mm |
18 mm |
| Battery longevity |
8–13 years†2,4 |
12 years‡5 |
| Accelerometer-based mechanical atrial sensing |
Yes |
N/A |
| Accelerometer-based rate response |
Yes |
Yes |
| MRI SureScan™ |
1.5T and 3T |
1.5T and 3T |
| CareLink™ remote monitoring |
Yes |
Yes |
Meet our next generation of Micra leadless pacemakers:
Micra™ AV2 and Micra™ VR2
Related pages
Medtronic 24-hour support
Educational resources on Medtronic Academy
Access interactive courses, videos, and educational resources to extend your learning on Micra.
1
Nippoldt D, Whiting J. Micra Transcatheter Pacing System: Device Volume Characterization Comparison. November 2014. Medtronic Data on File.
2
Reynolds DW, Duray GZ, Omar R, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. Published online November 9, 2015.
3
El-Chami M, et al. Leadless Pacemaker Implant in Patients with Pre-Existing Infections: Results from the Micra Post-Approval Registry. Presented at HRS May 2018. Boston, MA
4
Williams E, Whiting J. Micra Transcatheter Pacing System Size Comparison, November 2014, Medtronic Data on File.
5
Duray GZ. Ritter P, el-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. Published online February 10, 2017.
* The single chamber Micra™ transcatheter pacing system is being described herein as Micra™ VR in order to distinguish it from the (VDD) Micra™ AV product. When information in this document relates to both Micra™ AV and VR, “Micra™ transcatheter pacing systems” is used to represent the portfolio of devices.
† Use conditions include:
8 years = 100% VDD pacing, 60 bpm, pacing threshold 1.5 V, impedance 500 Ω, pulse width 0.24 ms.
13 years = 15% VDD pacing, 70 bpm, pacing threshold 1.5 V, impedance 600 Ω, pulse width 0.24 ms.
‡ Use conditions included: median pacing 53.5%, median pacing threshold 0.50 V, median impedance 543 Ω; 89% of patients with > 10-year projected longevity; 99% of patients with > 5-year longevity.5
- Micra™ AV and Micra™ VR, Licensed as MICRA VR2/MICRA AV2 TRANSCATHETER PACING SYSTEM